Hepatitis C Protein Serina Macrocyclohexanes Inhibitor (Second Application Patent No. A-2011-00056).

摘要

The present invention is related to a new macrocycle with anti-hepatitis C virus activity and can be used to treat HCB infection. More specifically, inventions are related to new macrochemical compounds, compounds containing these compounds, methods of using them, and the process of obtaining them.